Connect with us

News

British journalist produces excellent story on yesterday’s riot in DC

Published

1 minute read

Today we are all reacting to yesterday’s riots in Washington where Trump supporters stormed the Capitol building.  Here’s an excellent story from the UK’s ITV News. Reported by its Washington correspondent Robert Moore, much of the footage is shot inside as the violent mob stormed in through doors and broken windows.

It’s well done and a shining example of great reporting. Cudos to Mr. Moore and his crew who reported what they saw, asked questions, and put together an extraordinary piece while being in significant danger.

After excusing violence, Trump acknowledges Biden transition

President Todayville Inc., Honorary Colonel 41 Signal Regiment, Board Member Lieutenant Governor of Alberta Arts Award Foundation, Director Canadian Forces Liaison Council (Alberta) musician, photographer, former VP/GM CTV Edmonton.

Follow Author

Top Story CP

CFL leaves door open for Argos' quarterback Bethel-Thompson playing in East final

Published on

TORONTO — The CFL has left the door open to McLeod Bethel-Thompson playing in the East Division final Sunday.

The Toronto Argonauts starting quarterback was held out of practice and sent home Friday after attending the Toronto Raptors 97-93 home win over the Milwaukee Bucks on Thursday night.

That violated the CFL’s COVID-19 protocol, which would’ve normally meant Bethel-Thompson having to quarantine for four days and provide two negative tests before being able to resume team activities.

But Toronto hosts the Hamilton Tiger-Cats in the conference final Sunday afternoon at BMO Field.

The CFL announced Friday afternoon Bethel-Thompson will be allowed to play Sunday if he produces negative COVID testing following a 48-hour quarantine at his residence.

Argos Dexter McCoil, Charleston Hughes, Llevi Noel and Jeff Richards also attended the basketball game and will be subject to the same requirements as Bethel-Thompson.

Toronto (9-5) finished atop the East Division standings to secure home-field advantage for the conference final.

Bethel-Thompson was 7-2 as Toronto’s starter this season.

Both the Argos and Raptors are owned by Maple Leafs Sports & Entertainment.

If Bethel-Thompson can’t play, Antonio Pipkin will start for Toronto on Sunday.

The six-foot-three, 225-pound Pipkin started Toronto’s season-ending 13-7 home loss to Edmonton on Nov. 16, completing 10-of-22 passes for 111 yards and an interception while rushing for 78 yards and a TD on nine carries.

Video of Bethel-Thompson holding his infant daughter at the NBA game was carried on the Argos’ Twitter account Thursday night but was no longer available Friday.

But it was present long enough for Hamilton receiver Brandon Banks to notice.

“Wow when I tried to go to raptors game the @cfl told me I couldn’t go!” Banks tweeted. “I ain’t snitching but shit fishy ! #Protocol #tier1.”

Bethel-Thompson also appeared on TSN’s broadcast of the Raptors-Bucks game.

TSN is the CFL’s broadcast partner.

“So lemme get this straight,” TSN’s Kayla Grey, who interviewed Bethel-Thompson during the broadcast, tweeted Friday. ” … a starting quarterback goes on a national broadcast to promote an East Final that he is now forced to miss because the league is forcing him to quarantine for going to a game to promote said East Final?

“Baby what a mess.”

This report by The Canadian Press was first published Dec. 3, 2021.

The Canadian Press

Continue Reading

Top Story CP

Canada buying up to 1.5 million courses of oral antiviral drugs to fight COVID-19

Published on

OTTAWA — Procurement Minister Filomena Tassi says Canada has signed agreements to buy up 1.5 million courses of oral antiviral treatment for COVID-19.

The government has signed up for an initial one million courses of antiviral treatment, once Health Canada endorses their safety and efficacy.

Pfizer submitted a request for Health Canada approval earlier this week.

Canada has also purchased 500,000 courses of Merck’s oral antiviral treatment for COVID-19, with the option to purchase another 500,000 once Health Canada approves the drug.

The drugs are designed to block the enzyme essential for viral replication.

Merck’s clinical trial showed a 50 per cent reduced risk of hospitalization or death compared to placebo patients with mild or moderate COVID-19.

This report by The Canadian Press was first published Dec. 3, 2021.

The Canadian Press

Continue Reading

Trending

X